{"schema_version":"1","generated_at":"2026-10-29T21:30:23.515Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jimmie-harvey","json_url":"https://www.findmykol.com/kol/jimmie-harvey/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jimmie-harvey","name":"Jimmie Harvey","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Duke Medical Center","institution_url":"https://www.findmykol.com/institution/duke-medical-center","city":"Birmingham","state":"AL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1801813357","openalex":"A5109356262"},"summary":"Jimmie Harvey is an Oncology physician affiliated with Duke Medical Center. OpenAlex indexes 20 publications with 3,694 citations (h-index 14).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":20,"cited_by_count":3694,"h_index":14,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":27.15,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801813357"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2022,"amount_usd":45.76,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801813357"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2021,"amount_usd":53.14,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1801813357"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1801813357","source":"payments"},"prescribing":{"data_year":2020,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":2,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":84.4,"drugs":[{"name":"Anastrozole","share_pct":60},{"name":"Letrozole","share_pct":40}],"max_beneficiaries":null},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":15.6,"drugs":[{"name":"Tasigna","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2020,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":20,"shown":5,"withheld":15,"matched_by":"OpenAlex author record","recent":[{"title":"Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial","year":2017,"journal":"Journal of Hematology & Oncology","source_url":"https://doi.org/10.1186/s13045-017-0417-z","status":"verified"},{"title":"Effects of Long-Term Ruxolitinib (RUX) on Bone Marrow (BM) Morphology in Patients with Myelofibrosis (MF) Enrolled in the COMFORT-I Study","year":2016,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.v128.22.1949.1949","status":"verified"},{"title":"Long-term outcomes of ruxolitinib (RUX) therapy in patients (pts) with myelofibrosis (MF): 5-year update from COMFORT-I.","year":2016,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.7012","status":"verified"},{"title":"Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I","year":2015,"journal":"Haematologica","source_url":"https://doi.org/10.3324/haematol.2014.115840","status":"verified"},{"title":"Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer","year":2014,"journal":"Clinical Lung Cancer","source_url":"https://doi.org/10.1016/j.cllc.2013.12.005","status":"verified"}],"source":"works"},"contact":{"address_1":"880 MONTCLAIR RD","address_2":"SUITE 675","city":"Birmingham","state":"AL","zip":"352131972","phone":"205-592-5077","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1801813357","source":"identity"},"similar":[{"name":"Scott Cousins","slug":"scott-cousins","institution":"Duke Medical Center","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/scott-cousins","json_url":"https://www.findmykol.com/kol/scott-cousins/profile.json"},{"name":"Keith Sullivan","slug":"keith-sullivan","institution":"Duke Medical Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/keith-sullivan","json_url":"https://www.findmykol.com/kol/keith-sullivan/profile.json"},{"name":"David Durack","slug":"david-durack","institution":"Duke Medical Center","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/david-durack","json_url":"https://www.findmykol.com/kol/david-durack/profile.json"},{"name":"Thomas Bashore","slug":"thomas-bashore","institution":"Duke Medical Center","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/thomas-bashore","json_url":"https://www.findmykol.com/kol/thomas-bashore/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":15}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2007-11-06","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020}},"methodology_url":"https://www.findmykol.com/about#methodology"}